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Abstract
 
Introduction:  Lyme disease is caused by the tick-borne spirochete Borrelia burgdorferi.  
Research has shown that dogs can be used as sentinels for human infection of Lyme disease.  
The purpose of this 5-year, retrospective study was to determine if there was any evidence that 
the incidence of canine Lyme disease has increased between 2000 and 2005 in Accomack and 
Northampton counties.  An increased incidence in Lyme disease in dogs may indicate an 
increased present or future risk of Lyme disease in humans. 
 
Methods:  Cases of canine Lyme disease were identified via practice invoicing systems and dogs 
that received doxycycline were entered into the database.  Demographic information and the 
absence or presence of clinical signs such as fever, lameness, articular swelling, 
lymphadenomegaly, anorexia, general malaise and improvement after antibiotic use were 
collected.  Testing history also was recorded. 
 
Results:  Cases of canine Lyme disease that met any definition were identified (n=1048).  Over 
the 5-year period the number of positive ELISA test results increased and the frequency of 
clinical signs decreased.  The incidence of disease meeting the practitioner’s definition increased 
until 2004 when the incidence dropped from 105.33 cases per 1,000 dogs to 56.93 cases per 
1,000.  The incidence of disease based on the study probable definition remained fairly constant 
with a high in 2002 of 2.94 cases per 1,000 dogs. 
 
Discussion:  Trends of canine Lyme disease coincided with the introduction and use of the in-
house ELISA test.  Practitioners could identify more dogs exposed to Borrelia burgdorferi.  The 
areas with the highest frequency of canine cases of Lyme disease also had the highest frequency 
of human cases reported to the Virginia Department of Health.  Further study could identify 
animals that tested positive and later developed clinical signs.  Using dogs as sentinels for human 
infection allows public health workers to identify endemic areas regardless of human case 
reports 
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Introduction 
 
 Lyme disease or Lyme borreliosis is caused by the tick-borne spirochete Borrelia 
burgdorferi which is part of a large group of Borrelia species that affects mammalian and avian 
hosts.  It is now the most commonly reported vector borne disease affecting humans in the 
United States.  Data from the Centers for Disease Control and Prevention (CDC) indicate that 
ninety-five percent of cases have been reported from 12 states, with the bulk of those cases being 
reported from the coastal region between Massachusetts and Virginia.1,2  The incidence in these 
12 states was 23.5 cases per 100,000 people in 2004 compared to a median incidence rate of 0.44 
per 100,000 people in the remaining states, including Washington DC.3  The difficulty of 
confirming a diagnosis and the large number of borrelial spirochetes, makes determining an 
exact prevalence and geographic distribution controversial. 
The vectors of Lyme disease are several species of hard ticks of the Ixodes complex, the 
distribution of which is associated with the prevalence of disease.1  Ixodes are parasites of birds 
as well as large and small mammals. The distribution of these ticks is largely determined by the 
distribution of their hosts.  Of the many Ixodes species found nationwide, the black legged or 
deer tick, Ixodes scapularis, is the most common carrier of Lyme disease in the eastern United 
States.4  Populations of Ixodes scapularis tend to be clustered within geographic locations and 
are typically plentiful in areas with sandy soils and lower elevations that are a moderate distance 
from forests and water.5  The coastal area of the Chesapeake Bay region is home to a relatively 
large number of Ixodes scapularis compared to Delaware, Maryland, New Jersey, Pennsylvania, 
and other regions of Virginia.  Borrelia burgdorferi has been found to be more prevalent in areas 
along the Atlantic Ocean than at inland sites around Williamsburg and Yorktown.6  The 
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blacklegged ticks are maintained by a number of vertebrate hosts and favorable environmental 
conditions, such as sandy soil, lower elevation, and moderate distance from water and forests.4   
  Ixodes scapularis ticks can become infected with Borrelia burgdorferi throughout their 
two year life cycle.  Adult ticks oviposit their eggs in the spring and the larvae that emerge feed 
once in the summer, usually on birds and small mammals.  The larvae then overwinter and, if 
they have fed on an infected host, they will molt into an infected nymph.  As nymphs typically 
feed on larger mammals such as dogs and deer, infected nymphs are believed to be primarily 
responsible for transmission of Borrelia burgdorferi to domestic animals and people.1 
Transmission from vector to host does not occur until the tick has been attached for more than 
twenty-four hours.3   Borrelia species do not live free in the environment and they depend on a 
host for their nutritional requirements.2   
 In humans, Lyme disease patients are most likely to have illness onset beginning in the 
summer months, with a peak in June and July, but onset can occur throughout the year.7  It is 
estimated that 90% of people exposed to Borrelia burgdorferi will manifest clinical symptoms.  
Early infections are often characterized by a distinct skin lesion, erythema migrans, which occurs 
at the site of the tick bite.2  In addition, these patients will often have a fever and other symptoms 
including fatigue, headache and generalized achiness.  Within several days to weeks of this first 
stage, patients may develop a disseminated infection that will affect multiple body systems 
resulting in, for example, a diffuse rash, migratory joint pain and neurologic abnormalities.  
Persistent infection can also be a feature of this disease with some patients experiencing cardiac, 
neurologic and/or musculoskeletal abnormalities for anywhere from a few weeks to years.   
While Lyme disease is diagnosed based on symptoms, objective physical findings and a 
history of possible exposure to infected ticks, the diagnosis may be supported by serological  
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tests.  The CDC recommends a two-step process when testing blood for evidence of 
Lyme disease in which samples are first tested by either an enzyme-linked immunosorbent assay 
(ELISA) or an indirect immunofluorescent antibody test (IFA), with samples yielding positive or 
equivocal results then tested with a Western immunoblot.2  These tests are poorly standardized 
and must be interpreted with caution.  False negatives may occur in early infection and in people 
treated with antibiotics in the early stages of the disease.  The IFA and ELISA may cross react in 
patients with syphilis, relapsing fever, leptospirosis, HIV infection, Rocky Mountain spotted 
fever, infectious mononucleosis, lupus or rheumatoid arthritis.8  Lyme disease can be treated 
effectively with antibiotics such as doxycycline and amoxicillin, especially if treatment is 
initiated early in the course of the infection.   
  The most common clinical signs of Lyme disease in dogs are fever (103.1-104.9º F), 
shifting leg lameness, general malaise, anorexia, and local lymphadenopathy.9  A severe protein-
losing nephropathy with renal failure has been putatively associated with canine Lyme disease, 
but because this has not been seen in any Lyme disease study model to date, it may be that Lyme 
seropositivity is merely a marker for tick exposure.6   In contrast to humans, clinical disease in 
dogs is only seen, on average, in five to ten percent of seropositive dogs.  In endemic areas, 75 
percent of the dog population may test positive.1  Diagnostic tests for Borrelia burgdorferi 
readily available to veterinarians include indirect immunofluorescent antibody (IFA), polymerase 
chain reaction (PCR) and Western immunoblot.  In addition, many veterinarians are now using 
an in-house, enzyme-linked immunosorbent assay (ELISA) test (SNAP 3Dx® ELISA test 
manufactured by IDEXX Laboratories, Westbrook, ME) to determine the antibody status of dogs.  
This test is useful in areas endemic to Lyme disease because it is convenient and reliable 
regardless of vaccine history.10   According to IDEXX Laboratories, in regard to Borrelia 
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Burgdorferi, this test’s sensitivity is 92% (95% CI 88-96%) and its specificity is 100% (95% CI 
97%-100%).11  The SNAP 3Dx® also tests for antibodies to canine heartworm antigen and 
Erhlichia Canis.  Because the SNAP 3Dx® includes a heartworm test, many veterinarians use it 
routinely to assess dogs with no clinical signs of disease.   
Research has shown that dogs can be used as sentinels for human infection of Lyme 
disease.  A study by Lindenmayer et al. revealed that canine seroprevalence was highly 
predictive of the incidence in humans.  This is an effective indicator of human risk of Lyme 
disease in the environment.12,13  This does not mean that dog owners are at a high risk of 
contracting Lyme disease.  Goossens et al. used hunting dogs to show that the seropositivity of a 
dog was not a significant indicator of increased risk of infection of Lyme disease for its owner.  
Direct transfer of ticks between dog and owner is not a substantial concern.  Dogs are more 
likely to be exposed to ticks carrying Borrelia burgdorferi because of their behavioral patterns.  
It is expected that dogs will be bitten more often than humans because of this, although an 
interesting finding of this study was that seroprevalence of antibodies against Borrelia 
burgdorferi in hunters and hunting dogs was similar.14          
As dogs are thought to be sensitive indicators of Lyme borreliosis and prevalence of 
Lyme borreliosis has been shown to correlate with the infection in humans, an increased 
incidence in Lyme disease in dogs may indicate an increased present or future risk of Lyme 
disease in humans.  In early 2005, veterinarians in Accomack and Northampton counties 
approached local public health authorities expressing concern with what they perceived to be an 
increased incidence in the number of canine Lyme disease cases in the area.  Local health 
authorities from the Eastern Shore Health District (ESHD) then contacted the Virginia 
Department of Health’s Office of Epidemiology (OE) to discuss the situation. In response, the 
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OE, in cooperation with local health authorities, designed a study to investigate trends in canine 
Lyme disease in the ESHD.   The purpose of this 5-year, retrospective study was to determine if 
there was any evidence that the incidence of canine Lyme disease has increased between 2000 
and 2005 in Accomack and Northampton counties.  An additional goal was to compare the study 
definition of Lyme disease with the veterinary practitioner definition.  This information will be 
valuable to the public health community in that it may help target populations at increased risk 
for Lyme disease so that educational programs and prevention methods can be implemented.1
 
Methods 
 Local health authorities were asked to offer guidance concerning veterinary hospital 
selection.  A representative from each predominantly small animal practice serving residents of 
Accomack and Northampton counties was contacted and asked to participate in a full chart 
review and hospital data analysis in regard to canine Lyme disease cases managed by his practice 
from January 1, 2000 through June 30, 2005.  This representative was also asked about his 
practice’s record keeping system and the ease with which individual charts meeting certain 
criteria could be identified for review.   During this initial contact, veterinarians also were asked 
to complete a survey that was designed to elicit information concerning Lyme disease case 
identification, testing protocols and treatment.  In addition, each practice also was asked to 
identify the antibiotic(s) that its veterinarians typically used when treating Lyme disease. The 
antibiotic of choice was identified as doxycycline and also was identified as the antibiotic that 
was used almost exclusively (~99%) for the treatment of tick-borne diseases in dogs in the 
practices surveyed.  In light of this, the method by which charts were identified for review was 
via practice invoice database searches that identified animals receiving doxycycline during the 
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time period being studied.  A questionnaire was then developed and subsequently written into an 
Access® database into which data from each chart was entered and stored.  
Cases were identified based on the first use of doxycycline for the treatment of Lyme 
disease during the study period.  Dogs were immediately excluded from the study if they did not 
have an address in Accomack or Northampton counties.  Dogs were also excluded if they were 
being treated with doxycycline for a condition other than Lyme disease.  Each case was entered 
into the database only once.  Based on the chart review, information pertaining to demographics 
and important clinical signs was collected for each dog including name, zip code, breed, age, 
month and year of initial diagnosis, antibiotic prescribed, length of antibiotic use, and whether 
there was improvement after antibiotics.  Patients were said to have improved after antibiotic 
treatment if one of the following three conditions was met:  there was written evidence in the 
record that the dog improved, there were no abnormalities noted during the physical exam 
subsequent to the clinically ill event or, in cases where a positive test result was the only 
abnormal finding, the subsequent test result was negative.  The presence or absence of the 
following symptoms was also recorded:  lameness, fever, articular swelling, lymphadenomegaly, 
anorexia, and general malaise.  Fever was classified as none, any elevation (defined as >102º F 
up to and including 103º F), and greater than 103º F.  Only Lyme antibody results were gathered 
for years subsequent to the initial case entry.  
 Lyme vaccine history also was recorded.  This variable was categorized as:  none, 
vaccine within one year (of entry into the database), only one vaccine greater than one year ago, 
and one or more vaccines greater than one year ago.  Test results indicating co-infection with 
regards to Rocky Mountain Spotted Fever, Ehrlichia, and heartworm at the time of initial 
treatment with doxycycline also were recorded.     
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The date, result, and reason for treating with antibiotics also were included.  Reason for 
treating was classified in one of three ways:  practitioner case definition, probable case definition 
or confirmed case definition.  A probable case was defined as any dog having a fever greater 
than 103º F and lameness with at least one of the following: articular swelling, 
lymphadenomegaly, anorexia, or general malaise that showed improvement after antibiotic 
treatment.  A confirmed case was defined as any dog having a fever greater than 103º F and 
lameness with one of the following: articular swelling, lymphadenomegaly, anorexia, or general 
malaise that showed improvement after antibiotic treatment and positive results using at least 
two of the following tests: ELISA or IFA, Western blot, PCR, or spirochete identification on 
renal impression smears.  Culture of spirochetes alone of those dogs meeting the clinical aspect 
of this case definition was sufficient to confirm a case.  All other cases were categorized as 
practitioner definition if they were treated, but did not meet either the probable or confirmed case 
definition.    
Results of any subsequent tests performed also were captured.  The type of test, result, 
and reason for testing was recorded.  In addition, two categories were added to the list of those 
used to classify the reason for subsequent testing.  The response “annual test” was used if no 
treatment was initiated at that exam.  If it was unclear why subsequent tests were performed, the 
category “no definition met” was used.   
Descriptive statistical analyses were conducted using SPSS version13.0 (SPSS Inc, 
Chicago, IL).  Proportions and percentages were calculated for the categorical variables of 
interest.  Bar charts and histograms were used to provide a visual representation of trends in the 
data over the study period.  ArcGIS version 9.1 (ESRI, Redlands, CA) was used to map canine 
and human cases of Lyme disease in the Eastern Shore Health District by zip code.  The human 
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Lyme disease data were obtained from the Virginia Department of Health’s database of 
reportable diseases. 
 
Results 
Two hospitals (Hospital A and Hospital B) volunteered to participate in the study. Chart 
review and data entry were conducted from June through August 2005.  Hospital A contributed 
907 records and Hospital B contributed 141 records.  Hospital A contributed records for the 
entire study period and reported having 3,439 canine visits in 2000, 3,825 canine visits in 2001, 
4,079 canine visits in 2002, 4,111 canine visits in 2003, 4,040 canine visits in 2004, and 2,864 
canine visits through June 30, 2005.  Hospital B contributed records from January 1, 2004 to 
June 30, 2005 and reported having 1,884 canine visits during that period.   
AVImark® veterinary management software was used by both practices.  Through this 
software, reports were generated for animals that received doxycycline between January 1, 2000 
and June 30, 2005, inclusive for Hospital A and January 1, 2004 through June 30, 2005 for 
Hospital B.  During this time 1,048 cases of Lyme disease, meeting any definition, were 
diagnosed.  Hospital A reported 907 (86.3%) canine cases and Hospital B reported 141 (13.5%) 
cases.  Figure 1 shows the total number of cases that met any definition per year.  The most cases 
were seen in 2003 (n=433) followed by 2004 (n=349), 2002 (n=114), 2001 (n=49), 2000 (n=28).  
The majority of cases over the five year period were seen during the summer months, as shown 
in Figure 2.    
Table 1 shows the frequencies of selected variables including lameness, fever, articular 
swelling, lymphadenomegaly, anorexia, general malaise, improvement after antibiotics, and 
vaccine history over the entire five year period.  All dogs in the study met the practitioner’s 
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definition because the treatment of Lyme disease was the basis on which cases were selected.  A 
small subset of cases met the other study case definitions as well.     
In Table 2, the frequency of clinical signs, test results, and dogs that meet the study 
probable definition per year for Hospital A are shown.  In 2000, Hospital A reported 28 cases of 
Lyme disease that met any definition, and from 2001 through June 2005 Hospital A reported 44 
cases, 114 cases, 433 cases, 230 cases, and 53 cases respectively.  The highest percentage of 
dogs met the study probable definition in 2001 and in 2002.  In 2000 lameness was seen in 
64.3% of dogs, in 2001 73.5%, and in 2002 50.9%.  In 2000 32.1 % of dogs exhibited fever 
greater than 103º F, in 2001 32.8%, and in 2003 9.0%.  The percentage of dogs having a fever of 
any elevation remained fairly constant.  The percentage of dogs having lymphadenomegaly was 
low throughout the study period with 18.4% in 2001 and 3.9% in 2004.   In 2000 32.1% of dogs 
showed signs of anorexia, 2001, 24.5%, and in 2002, 22.8%.   In 2000, 50% of dogs had general 
malaise and in 2003, 7.6%.  The highest percentage of dogs showed improvement after antibiotic 
use in 2000 and in 2001.  A high percentage of positive tests was seen in all years.  In Figure 3, 
the trends of animals testing positive are compared to the clinical signs used in the study case 
definitions and animals meeting the study probable definition over the study period.  Over the 
years the number of positive tests increased as the number of animals showing fever >103º F, 
lameness, improvement after antibiotics, and meeting the study probable definition decreased.   
The incidence of Lyme disease over the study period was calculated using the number of 
cases that meet the practitioner’s definition and the number of cases meeting the study probable 
definition for hospital A.  The number of canine visits per year to hospital A was used as the 
denominator.  The incidence (practitioner’s definition) in 2000 was 8.14 cases per 1,000 dogs, in 
2001 was 12.81 per 1,000, in 2002 was 27.95 per 1,000, in 2003 was 105.33 per 1,000, in 2004 
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was 56.93 per 1,000, and in 2005 was 18.51 per 1,000.  The incidence of dogs meeting the study 
probable definition in 2000 was 1.16 per 1,000, in 2001 was 1.83 per 1,000, in 2002 was 2.94 per 
1,000, in 2003 was 1.22 per 1,000, in 2004 was 0.50 per 1,000, and in 2005 was 1.05 per 1,000.  
In Figure 4, the incidence of cases meeting the study probable definition and cases meeting the 
practitioner’s definition is graphically illustrated.     
Table 3 illustrates the frequency of clinical signs, test results, and dogs that met the study 
probable definition from 2004 though June 2005 for Hospital B.  In 2004 there were 230 cases of 
Lyme disease that met any definition and in 2005 there were 53 cases.  None of these cases met 
the study probable definition.  In 2004 87.4% (n=104) of cases tested positive and in 2005 86.4% 
(n=19) tested positive.  
In Table 4, the zip codes for the home address of cases that meet any definition are 
presented.  The highest percentage of cases was seen in Cape Charles, 23310 (9.83%), 
Onancock, 23417 (9.45%), Exmore, 23350 (7.92%), Belle Haven, 23306 (5.34%), and Eastville, 
23347 (5.15%).  Table 5 shows where the cases meeting the study probable definition were 
located.  Belle Haven, 23306 and Cape Charles, 23310 both had 12.12% of the cases that meet 
the study probable definition.  Figure 5 maps the human cases of Lyme disease on the Eastern 
Shore health district between 2000 and 2004.  There were 2 cases with unknown zip codes.  
Figure 6 maps the cases of canine Lyme disease that meet any definition between 2000 and 
2005.  Figure 7 maps the distribution of dogs testing seropositive to Borrelia burgdorferi on the 
Eastern Shore in 2004. 
 
Discussion  
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The purpose of this 5-year, retrospective study was to determine if there was any 
evidence that the incidence of canine Lyme disease increased between 2000 and 2005 in 
Accomack and Northampton counties.  An additional goal was to compare the study definition of 
Lyme disease with the veterinary practitioner definition.  The hospitals that volunteered to 
participate in this study are both predominately (> 85%) small animal practices.  Hospital A 
employs five veterinarians and reports having approximately 4,000 canine visits per year 
throughout the study period.  Hospital B is a solo practice that reports having over 1,000 canine 
visits per year.  
The number of dogs meeting the practitioner’s definition increased between 2000 and 
2003.  There was a slight decrease in number beginning in 2004 which continued through 2005.  
It is important to remember that the 2005 data includes only cases through June 30, 2005.  Since 
Lyme disease varies by season, with more cases identified in the summer months, the decrease in 
incidence for this time period should be interpreted with caution.  The incidence of Lyme disease 
in dogs meeting the study probable definition increased until 2002 and began to decrease in 
2003.  This coincides with Hospital A’s use of the in-house ELISA test.  The hospital started 
using this test in April 2001; however, testing of all dogs became standard practice protocol in 
June 2002.  Hospital B began using this same test in 2004 as a routine part of canine exams.  The 
ELISA test made it possible to capture more dogs that were exposed to Borrelia burgdorferi.   
Over the 5 year period lameness, fever, articular swelling, lymphadenopathy, general 
malaise, anorexia, and improvement after antibiotics were seen in a small percentage of cases.  
Dogs having lameness and improvement after antibiotics were the highest percentages seen, 
24.6% and 27.5%, respectively.  As use of the ELISA test became more prevalent the number of 
positive test results per year of dogs that were treated for Lyme disease increased until 2004 
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when the number decreased slightly.  The ELISA test has been shown to be useful in highly 
Lyme-endemic areas because it is convenient and reliable.  Vaccination history does not affect 
the reliability of this test.9  In this study 89.9% of dogs had no history of vaccine.  Over this 
period there was a sharp decrease in the number of dogs exhibiting clinical signs and meeting the 
study probable definition.  In 2003 84.5% of cases from Hospital A tested positive compared to 
only 18.7% showing signs of lameness.  At this time only 1.2% of cases met the study probable 
definition.      
There seems to be an increasing trend in the decision to treat dogs with doxycycline on 
the basis of a positive test results regardless of clinical signs.  It is the practitioner’s clinical 
impression that those animals left untreated will return to the clinic with clinical disease.  While 
prophylactic treatment is not unfounded, it may be necessary to determine the true number of 
dogs that have clinical disease in order define practice protocol.  It would be helpful to determine 
the percentage of dogs that will manifest clinical Lyme disease in this area to asses whether the 
percentage exceeds the national average to a point where prophylactic treatment is indicated.     
The human and canine cases of Lyme disease were mapped to see the similarities and 
differences between the two.  Since the geographic distribution of Lyme disease is believed to be 
clustered in certain locations mapping the canine cases might show where human cases are 
underreported or under diagnosed.  For example no human cases of Lyme disease were reported 
in the southern most tip of the Eastern Shore Health District, but there was high density of canine 
cases.  Glavanakov et al. showed a consistent pattern of spatial dependence in the state of New 
York.15  Similarities have been seen in the Eastern Shore health district.  Figure 5, 6, and 7 depict 
a high frequency of cases located at 23350 and 23417.  These areas had a high frequency of 
human cases, canine cases that meet any definition, and dogs testing seropositive in 2004.   
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Since this was a volunteer study, some cases of Lyme disease may have been missed 
because those dogs visited other clinics.  Not all hospitals in the area were able to participate 
because the limitations of computer software and record keeping systems did not allow those 
dogs prescribed doxycycline to be identified.  Dogs that never visited an animal hospital were 
also missed and so the data collected may not be completely representative of the population.  
Using canine visits per year as the dominator for the incidence data was a further limitation.  In 
some years dogs will visit the animal hospital more than once which may create a false 
impression of the number of dogs each hospital considers as patients. The number had to be used 
because there was no way to determine the total number of canines that were seen for any reason 
per year.  Since Lyme disease is believed to be underreported, there could be more human cases 
than were reported to the Virginia Department of Health.  This would affect the map of human 
cases of Lyme disease on the Eastern Shore of Virginia between 2000 and 2004. 
To further assess trends in canine Lyme disease a prospective study needs to done to 
determine the percentage of dogs that go on to develop clinical signs.  Having an appreciation for 
the percentage of dogs in this endemic area that tested positive to Borrelia burgdorferi and later 
developed clinical signs would be important in assessing prophylactic doxycycline use.  This 
information would be more valuable in locating areas where humans are at a greater risk or 
human cases are underreported. 
Even though it is difficult to standardize canine Lyme disease testing protocols because 
of the lack of a widely recognized clinically defined case definition, canines are still effective 
predictors of the level of Borrelia burgdorferi in an area.14   Using dogs as sentinels for human 
infection allows public health workers to identify endemic areas regardless of human case 
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reports.  This information will help public health officials pinpoint areas in which surveillance 
should be increased to lessen the risk of human infection.  
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Figure 1. Annual Cumulative Cases of Lyme Disease 
per Year Meeting Any Definition from Hospital A and B
0
50
100
150
200
250
300
350
400
450
500
Y2000 Y2001 Y2002 Y2003 Y2004 Y2005
Year
C
as
es
 
 
 
 
 
 
 
   
 16
Figure 2. Practice Defined Lyme Disease Cases per Month 
Meeting any Definition From Hospital A and B, January 1, 2000 
to June 30, 2005
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Table 1.  Frequencies of Selected Variables From Hospital A and B, 
2000-2005 
        
 Total  Percentage     
       Variable 
 N  %       
Lameness        
No  790  75.3    
Yes  250  24.6    
        
Fever        
None  776  74.0    
Any Elevation  157  15.0    
> 103  115  11.0    
        
Articular Swelling        
No  1037  98.9    
Yes  11  1.0    
        
Lymphadenomegaly        
No  995  94.9    
Yes  53  5.1    
        
Anorexia        
No  956  91.9    
Yes  92  8.8    
        
General Malaise        
No  911  86.8    
Yes  137  13.1    
        
Improvement after Antibiotics      
No  760  72.1    
Yes  288  27.5    
        
Vaccine        
None  939  89.9    
Within 1 year  79  7.6    
> 1 year once  8  0.8    
> 1 year Multiple  21  2.0    
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Table 2.  Frequency of Clinical Signs and Test Results per Year for Hospital A, 
2000-2005 
 
                
Year  2000 2001 2002 2003 2004 2005 
        
    N (%) N (%)  N (%) N (%) N (%) N (%)  
Total Cases 28 44 114 433 230 53 
        
Study probable 4 ( 14.3) 7 (14.3) 12 (10.5) 5 (1.2) 2 (0.9) 3 (5.7) 
        
Lameness 18 (64.3) 36 (73.5) 58 (50.9) 81 (18.7) 41 (17.8) 20 (37.7) 
        
Fever >103 9 (32.1) 19 (32.8) 28 (24.6) 39 (9.0 ) 12 (5.2) 8 (15.1) 
        
Any Fever  6 (21.4) 11 (22.4) 24 (21.1) 64 (14.8) 39 (17.0) 11 (20.8) 
        
Lymphadenomegaly 2 (7.1)  9 (18.4) 8 (7.0) 19 (4.4) 9 (3.9) 4 (7.5) 
        
Anorexia  9 (32.1)  12 (24.5) 26 (22.8) 21 (4.8) 14 (6.1) 7 (13.2) 
        
Articular Swelling 1 (3.6) 1 (2.0) 2 (1.8) 4 (0.9) 1 (0.4) 3 (3.8) 
        
Malaise  14 (50.0) 14 (28.6) 36 (31.6) 33 (7.6) 23 (10.0) 11 (20.8) 
        
Improvement after 
Antibiotics 22 (78.6) 36 (73.5) 50 (43.9) 119 (27.5) 46 (20.0) 4 (7.5) 
        
Positive test 9 (32.1) 24 (49.0) 88 (77.2) 366 (84.5) 189 (82.2) 43 (81.1)  
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Figure 3.  Percentage of Positive Test Compared to Other Clinical Signs and 
Study Probable Definition for Hospital A, 2000-2005
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Table 3.  Frequency of Clinical Signs and Test Results per Year for Hospital 
B for 2004-2005 (no data for 2000-2003) 
 
      2004  2005   
Year        
   N (%)  N (%)    
          
Total Cases   119  22   
        
Study probable  0 (0.0)  0 (0.0)   
        
Lameness  3 (2.5)  1 (4.5)   
        
Fever >103  0 (0.0)  0 (0.0)   
        
Any fever   2 (1.7)  0 (0.0)   
        
Lymphadenomegaly  2 (1.7)  0 (0.0)   
        
Articular Swelling  0 (0.0)  0 (0.0)   
        
Anorexia   3 (2.5)  0 (0.0)   
        
Malaise   5 (4.2)  1 (4.5)   
        
Improvement after antibiotics  10 (8.4)  1 (4.5)   
        
Positive test  104 (87.4)  19 (86.4)   
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Table 4.  Cases Meeting Any Definition Stratified by 
Zipcode, 2000-2005 
 
Total  Percentage     
      Zipcode 
N  %       
23301 48  4.58    
23302 4  0.38    
23303 6  0.57    
23306 56  5.34    
23307 15  1.43    
23308 14  1.34    
23310 103  9.83    
23313 7  0.67    
23316 42  4.01    
23336 29  2.77    
23337 4  0.38    
23341 8  0.76    
23347 54  5.15    
23350 83  7.92    
23354 29  2.77    
23356 4  0.38    
23357 4  0.38    
23358 6  0.57    
23359 4  0.38    
23389 3  0.29    
23395 3  0.29    
23398 22  2.10    
23399 1  0.10    
23401 18  1.72    
23404 4  0.38    
23405 51  4.87    
23407 1  0.10    
23408 6  0.57    
23409 1  0.10    
23410 51  4.87    
23413 36  3.44    
23414 1  0.10    
23415 5  0.48    
23416 1  0.10    
23417 99  9.45    
23418 43  4.10    
23420 49  4.68    
23421 24  2.29    
23422 31  2.96    
23423 23  2.19    
23427 3  0.29    
23429 2  0.19    
23441 1  0.10    
   
 23
23442 5  0.48    
23443 13  1.24    
23480 21  2.00    
23483 1  0.10    
23486 9  0.86    
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Table 5.  Canine Cases Meeting the Study Probable Definition by 
Zipcode, 2000-2005 
 
Total  Percentage       
       Zipcode 
N  %         
23301 2  6.06     
23306 4  12.12     
23310 4  12.12     
23316 2  6.06     
23336 1  3.03     
23347 3  9.09     
23350 1  3.03     
23398 1  3.03     
23401 2  6.06     
23405 3  9.09     
23417 3  9.09     
23418 2  6.06     
23420 3  9.09     
23422 1  3.03     
23423 1  3.03     
        
Total 33  100     
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Figure 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 26
Figure 6. 
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e Figure 7.
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Appendix A 
 
Lyme Disease Case Definition Survey 
 
Name:        
 
Practice name:       
 
Date:        
 
1.  Please choose the statement that represents the least amount of information that you would 
need to have before initiating treatment for what you suspected was acute canine Lyme disease:  
 a. Fever (any elevation) and lameness.   
 
b. Fever (>103°) and lameness. 
 
 c. Fever (>103°) and lameness plus at least one of the following:  articular  
 swelling, lymphadenomegaly, anorexia or general malaise. 
 
 d. Fever (>103°) and lameness plus at least one of the following:  articular  swelling, 
lymphadenomegaly, anorexia or general malaise and positive results  using any one 
serologic test. 
 
 e. Fever (>103°) and lameness plus at least two of the following:  articular  swelling, 
lymphadenomegaly, anorexia or general malaise and positive results  using any one 
serologic test.   
 
 f. Fever (>103°) and lameness plus at least one of the following:  articular  swelling, 
lymphadenomegaly, anorexia or general malaise and positive results  using at least two of 
the following laboratory tests:  ELISA or IFA, Western blot,  PCR, spirochete 
identification on renal impression smears or culture of  spirochetes. 
   
 g. Other:          
            
            
 
 
2.  Does your practice offer a Lyme ELISA test? Yes No 
 If no skip to question #7 
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3.  How long has you practice been using this type of test?  (Circle the first year a test like this 
was offered) 
  
 a. 2000 
 b. 2001 
 c. 2002 
 d. 2003 
 e. 2004 
 f.  2005 
 g. Other:    
 
 
4.  What is the brand name of the Lyme ELISA test your practice currently uses? 
        
 
 
5.  When do you typically use the Lyme ELISA test? (choose all that apply) 
  
 a. During routine physical exams on dogs whether or not any clinical signs of  Lyme 
disease are found. 
 
 b. If clinical signs compatible with Lyme disease are found on physical exam. 
  
 c. I rarely or never use this test eventhough my practice offers it.   
 
 d. Other:          
            
              
 
 
6.  If a dog tests positive using the Lyme ELISA, which statement below represents your most 
common clinical response: (please choose only one) 
  
 a. I initiate treatment whether compatible clinical signs of Lyme are present or  not as 
it has been my experience that many dogs will develop signs if I do not. 
 
 b. I discuss Lyme disease and its clinical signs with the owner and tell the owner  that the 
dog will need to be rechecked if those signs develop.   
 
 c. I recommend further testing, especially if clinical signs are not present. 
 
 d. Other:          
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7.  If you do not use the Lyme ELISA or often recommend some other testing, what tests do you 
initiate?  (choose all that apply) 
  
 a. IFA 
 
 b. Western Blot 
 
 c. PCR 
 
 d. spirochete identification on renal impression smears  
 
 e. culture of  spirochetes  
 
 f. Other:          
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Appendix B 
SPSS Syntax 
 
**To label test_result 1-5, to make values numeric rather than string** 
 
COMPUTE result_1= 0. 
If test_res_1='Positive' result_1=1. 
If test_res_1='Weak Positive' result_1=1. 
If test_res_1='Negative' result_1=2. 
EXECUTE. 
freq var result_1. 
 
COMPUTE result_2= 0. 
If test_res_2='Positive' result_2=1. 
If test_res_2='Weak Positive' result_2=1. 
If test_res_2='Negative' result_2=2. 
EXECUTE. 
freq var result_2. 
 
COMPUTE result_3= 0. 
If test_res_3='Positive' result_3=1. 
If test_res_3='Weak Positive' result_3=1. 
If test_res_3='Negative' result_3=2. 
EXECUTE. 
freq var result_3. 
 
COMPUTE result_4= 0. 
If test_res_4='Positive' result_4=1. 
If test_res_4='Weak Positive' result_4=1. 
If test_res_4='Negative' result_4=2. 
EXECUTE. 
freq var result_4. 
 
COMPUTE result_5= 0. 
If test_res_5='Positive' result_5=1. 
If test_res_5='Weak Positive' result_5=1. 
If test_res_5='Negative' result_5=2. 
EXECUTE. 
freq var result_5. 
 
**mult_positive variable created to capture patients with 1 or more positive or weak positive test results 
(vars result_1 thru result_5)** 
 
COMPUTE mult_positive = 0. 
EXECUTE. 
If result_1=1 and result_2=1 or result_3=1 or result_4=1 or result_5=1 mult_positive=1. 
EXECUTE. 
freq var mult_positive. 
VALUE LABEL mult_positive 0 'Negative' 1 'Positive'. 
 
**New variable, criteria met/not met for study prob def** 
 
COMPUTE study_prob_def = 0. 
EXECUTE. 
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If ((fever_str='>103') and (lameness_str='Yes') and (abx_str='Yes') and (other_signs=1)) 
study_prob_def=1. 
EXECUTE. 
freq var study_prob_def. 
 
 
COMPUTE other_signs=0. 
EXECUTE. 
If articular_str='Yes' or lymph_str='Yes' or anorex_str='Yes' or malaise_str='Yes' other_signs=1. 
EXECUTE. 
freq var other_signs. 
 
*Frequncies* 
 
FREQUENCIES 
VARIABLES=Lameness Fever Articular Lymph Anorex Malaise Vac_ID abx_Improve Month_id Zipcode  
/ORDER ANALYSIS. 
 
*Signs by year* 
 
CROSSTABS 
/TABLES=Lameness Fever Articular Lymph Anorex Malaise Vac_ID abx_Improve Month_id Zipcode 
study_prob_def BY YEAR_id 
/FORMAT=AVALUE TABLES 
/CELLS=COUNT ROW 
/COUNT ROUND CELL. 
 
CROSSTABS 
/TABLES=Lameness Fever Articular Lymph Anorex Malaise abx_Improve abx_Improve study_prob_def 
result_1 BY YEAR_id by Practice_id 
/FORMAT=AVALUE TABLES 
/CELLS=COUNT COLUMN 
/COUNT ROUND CELL. 
 
CROSSTABS 
/TABLES=Lameness Fever abx_Improve result_1 study_prob_def BY YEAR_id by Practice_id 
/FORMAT=AVALUE TABLES 
/CELLS=COUNT COLUMN 
/COUNT ROUND CELL. 
 
CROSSTABS 
/TABLES=abx_Used BY study_prob_def 
/FORMAT=AVALUE TABLES 
/CELLS=COUNT ROW 
/COUNT ROUND CELL. 
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Appendix C 
SPSS Output 
 
Frequencies 
 
Statistics
result_1
1048
0
Valid
Missing
N
 
result_1
68 6.5 6.5 6.5
952 90.8 90.8 97.3
28 2.7 2.7 100.0
1048 100.0 100.0
Missing
Positive
Negative
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Frequencies 
 
Statistics
result_2
1048
0
Valid
Missing
N
 
result_2
578 55.2 55.2 55.2
345 32.9 32.9 88.1
125 11.9 11.9 100.0
1048 100.0 100.0
.00
1.00
2.00
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Frequencies 
 
Statistics
result_3
1048
0
Valid
Missing
N
 
 
Frequencies 
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Statistics
result_4
1048
0
Valid
Missing
N
 
result_4
1028 98.1 98.1 98.1
10 1.0 1.0 99.0
10 1.0 1.0 100.0
1048 100.0 100.0
.00
1.00
2.00
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Frequencies 
 
result_3
917 87.5 87.5 87.5
79 7.5 7.5 95.0
52 5.0 5.0 100.0
1048 100.0 100.0
.00
1.00
2.00
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Statistics
result_5
1048
0
Valid
Missing
N
 
 
result_5
1047 99.9 99.9 99.9
1 .1 .1 100.0
1048 100.0 100.0
.00
2.00
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Frequencies 
 
Statistics
mult_positive
1048
0
Valid
Missing
N
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mult_positive
700 66.8 66.8 66.8
348 33.2 33.2 100.0
1048 100.0 100.0
Negative
Positive
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Frequencies 
 
Statistics
study_prob_def
1048
0
Valid
Missing
N
 
study_prob_def
1015 96.9 96.9 96.9
33 3.1 3.1 100.0
1048 100.0 100.0
Does Not meet Study
Probable
Meets Study Probable
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Frequencies 
 
Statistics
other_signs
1048
0
Valid
Missing
N
 
other_signs
835 79.7 79.7 79.7
213 20.3 20.3 100.0
1048 100.0 100.0
0
1
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Frequencies 
 
Statistics
1048 1048 1048 1048 1048 1048 1048 1048 1048 1048
0 0 0 0 0 0 0 0 0 0
Valid
Missing
N
Lameness Fever Articular Lymph Anorex Malaise Vac_ID abx_Improve Month_id Zipcode
 
 
Frequency Table 
 
Lameness
790 75.4 75.4 75.4
258 24.6 24.6 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Fever
776 74.0 74.0 74.0
157 15.0 15.0 89.0
115 11.0 11.0 100.0
1048 100.0 100.0
None
Any Elevation
>103
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Articular
1037 99.0 99.0 99.0
11 1.0 1.0 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Lymph
995 94.9 94.9 94.9
53 5.1 5.1 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Anorex
956 91.2 91.2 91.2
92 8.8 8.8 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
Malaise
911 86.9 86.9 86.9
137 13.1 13.1 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
 
Vac_ID
1 .1 .1 .1
20 1.9 1.9 2.0
8 .8 .8 2.8
939 89.6 89.6 92.4
1 .1 .1 92.5
79 7.5 7.5 100.0
1048 100.0 100.0
> 1 Year Mulitple
> 1 Year Multiple
> 1 Year Once
NONE
With in 1 year
With in 1 Year
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
 
abx_Improve
760 72.5 72.5 72.5
288 27.5 27.5 100.0
1048 100.0 100.0
No
Yes
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Month_id
67 6.4 6.4 6.4
70 6.7 6.7 13.1
87 8.3 8.3 21.4
104 9.9 9.9 31.3
123 11.7 11.7 43.0
121 11.5 11.5 54.6
95 9.1 9.1 63.6
103 9.8 9.8 73.5
66 6.3 6.3 79.8
71 6.8 6.8 86.5
74 7.1 7.1 93.6
67 6.4 6.4 100.0
1048 100.0 100.0
January
February
March
April
May
June
July
August
September
October
Novemeber
December
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Zipcode
48 4.6 4.6 4.6
4 .4 .4 5.0
6 .6 .6 5.5
56 5.3 5.3 10.9
15 1.4 1.4 12.3
14 1.3 1.3 13.6
103 9.8 9.8 23.5
7 .7 .7 24.1
42 4.0 4.0 28.1
29 2.8 2.8 30.9
4 .4 .4 31.3
8 .8 .8 32.1
54 5.2 5.2 37.2
83 7.9 7.9 45.1
29 2.8 2.8 47.9
4 .4 .4 48.3
4 .4 .4 48.7
6 .6 .6 49.2
4 .4 .4 49.6
3 .3 .3 49.9
3 .3 .3 50.2
22 2.1 2.1 52.3
1 .1 .1 52.4
18 1.7 1.7 54.1
4 .4 .4 54.5
51 4.9 4.9 59.4
1 .1 .1 59.4
6 .6 .6 60.0
1 .1 .1 60.1
51 4.9 4.9 65.0
36 3.4 3.4 68.4
1 .1 .1 68.5
5 .5 .5 69.0
1 .1 .1 69.1
99 9.4 9.4 78.5
43 4.1 4.1 82.6
49 4.7 4.7 87.3
24 2.3 2.3 89.6
31 3.0 3.0 92.6
23 2.2 2.2 94.8
3 .3 .3 95.0
2 .2 .2 95.2
1 .1 .1 95.3
5 .5 .5 95.8
13 1.2 1.2 97.0
21 2.0 2.0 99.0
1 .1 .1 99.1
9 .9 .9 100.0
1048 100.0 100.0
23301.00
23302.00
23303.00
23306.00
23307.00
23308.00
23310.00
23313.00
23316.00
23336.00
23337.00
23341.00
23347.00
23350.00
23354.00
23356.00
23357.00
23358.00
23359.00
23389.00
23395.00
23398.00
23399.00
23401.00
23404.00
23405.00
23407.00
23408.00
23409.00
23410.00
23413.00
23414.00
23415.00
23416.00
23417.00
23418.00
23420.00
23421.00
23422.00
23423.00
23427.00
23429.00
23441.00
23442.00
23443.00
23480.00
23483.00
23486.00
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Crosstabs 
 
Case Processing Summary
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
Lameness * Year_id
Fever * Year_id
Articular * Year_id
Lymph * Year_id
Anorex * Year_id
Malaise * Year_id
Vac_ID * Year_id
abx_Improve * Year_id
Month_id * Year_id
Zipcode * Year_id
study_prob_def * Year_id
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
Lameness * Year_id Crosstabulation
10 13 56 352 305 54 790
1.3% 1.6% 7.1% 44.6% 38.6% 6.8% 100.0%
18 36 58 81 44 21 258
7.0% 14.0% 22.5% 31.4% 17.1% 8.1% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Lameness
Count
% within Lameness
Count
% within Lameness
No
Yes
Lameness
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
Fever * Year_id Crosstabulation
13 19 62 330 296 56 776
1.7% 2.4% 8.0% 42.5% 38.1% 7.2% 100.0%
6 11 24 64 41 11 157
3.8% 7.0% 15.3% 40.8% 26.1% 7.0% 100.0%
9 19 28 39 12 8 115
7.8% 16.5% 24.3% 33.9% 10.4% 7.0% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Fever
Count
% within Fever
Count
% within Fever
Count
% within Fever
None
Any Elevation
>103
Fever
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Articular * Year_id Crosstabulation
27 48 112 429 348 73 1037
2.6% 4.6% 10.8% 41.4% 33.6% 7.0% 100.0%
1 1 2 4 1 2 11
9.1% 9.1% 18.2% 36.4% 9.1% 18.2% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Articula
Count
% within Articula
Count
% within Articula
No
Yes
Articular
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
Lymph * Year_id Crosstabulation
26 40 106 414 338 71 995
2.6% 4.0% 10.7% 41.6% 34.0% 7.1% 100.0%
2 9 8 19 11 4 53
3.8% 17.0% 15.1% 35.8% 20.8% 7.5% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Lymph
Count
% within Lymph
Count
% within Lymph
No
Yes
Lymph
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
 
Anorex * Year_id Crosstabulation
19 37 88 412 332 68 956
2.0% 3.9% 9.2% 43.1% 34.7% 7.1% 100.0%
9 12 26 21 17 7 92
9.8% 13.0% 28.3% 22.8% 18.5% 7.6% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Anorex
Count
% within Anorex
Count
% within Anorex
No
Yes
Anorex
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
Malaise * Year_id Crosstabulation
14 35 78 400 321 63 911
1.5% 3.8% 8.6% 43.9% 35.2% 6.9% 100.0%
14 14 36 33 28 12 137
10.2% 10.2% 26.3% 24.1% 20.4% 8.8% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Malaise
Count
% within Malaise
Count
% within Malaise
No
Yes
Malaise
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Vac_ID * Year_id Crosstabulation
0 0 0 0 1 0 1
.0% .0% .0% .0% 100.0% .0% 100.0%
1 0 2 3 13 1 20
5.0% .0% 10.0% 15.0% 65.0% 5.0% 100.0%
0 0 3 2 2 1 8
.0% .0% 37.5% 25.0% 25.0% 12.5% 100.0%
26 45 96 405 299 68 939
2.8% 4.8% 10.2% 43.1% 31.8% 7.2% 100.0%
1 0 0 0 0 0 1
100.0% .0% .0% .0% .0% .0% 100.0%
0 4 13 23 34 5 79
.0% 5.1% 16.5% 29.1% 43.0% 6.3% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Vac_I
Count
% within Vac_I
Count
% within Vac_I
Count
% within Vac_I
Count
% within Vac_I
Count
% within Vac_I
Count
% within Vac_I
> 1 Year Mulitp
> 1 Year Multip
> 1 Year Once
NONE
With in 1 year
With in 1 Year
Vac_ID
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
 
abx_Improve * Year_id Crosstabulation
6 13 64 314 293 70 760
.8% 1.7% 8.4% 41.3% 38.6% 9.2% 100.0%
22 36 50 119 56 5 288
7.6% 12.5% 17.4% 41.3% 19.4% 1.7% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within abx_Im
Count
% within abx_Im
Count
% within abx_Im
No
Yes
abx_Impr
Total
2000.002001.002002.002003.002004.002005.00
Year_id
Total
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Month_id * Year_id Crosstabulation
1 3 1 27 24 11 67
1.5% 4.5% 1.5% 40.3% 35.8% 16.4% 100.0%
4 2 5 21 22 16 70
5.7% 2.9% 7.1% 30.0% 31.4% 22.9% 100.0%
0 1 4 28 33 21 87
.0% 1.1% 4.6% 32.2% 37.9% 24.1% 100.0%
3 6 6 43 37 9 104
2.9% 5.8% 5.8% 41.3% 35.6% 8.7% 100.0%
4 3 3 53 48 12 123
3.3% 2.4% 2.4% 43.1% 39.0% 9.8% 100.0%
3 10 15 48 39 6 121
2.5% 8.3% 12.4% 39.7% 32.2% 5.0% 100.0%
3 6 10 37 39 0 95
3.2% 6.3% 10.5% 38.9% 41.1% .0% 100.0%
6 3 6 60 28 0 103
5.8% 2.9% 5.8% 58.3% 27.2% .0% 100.0%
0 2 8 32 24 0 66
.0% 3.0% 12.1% 48.5% 36.4% .0% 100.0%
0 3 8 39 21 0 71
.0% 4.2% 11.3% 54.9% 29.6% .0% 100.0%
3 4 25 24 18 0 74
4.1% 5.4% 33.8% 32.4% 24.3% .0% 100.0%
1 6 23 21 16 0 67
1.5% 9.0% 34.3% 31.3% 23.9% .0% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
Count
% within Month_
January
February
March
April
May
June
July
August
September
October
Novemebe
December
Month_id
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
 
 
 
study_prob_def * Year_id Crosstabulation
24 42 102 428 347 72 1015
2.4% 4.1% 10.0% 42.2% 34.2% 7.1% 100.0%
4 7 12 5 2 3 33
12.1% 21.2% 36.4% 15.2% 6.1% 9.1% 100.0%
28 49 114 433 349 75 1048
2.7% 4.7% 10.9% 41.3% 33.3% 7.2% 100.0%
Count
% within study_prob_de
Count
% within study_prob_de
Count
% within study_prob_de
Does Not meet Study
Probable
Meets Study Probab
study_prob_def
Total
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Crosstabs 
 
Case Processing Summary
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
Lameness * Year_id
* Practice_id
Fever * Year_id *
Practice_id
Articular * Year_id *
Practice_id
Lymph * Year_id *
Practice_id
Anorex * Year_id *
Practice_id
Malaise * Year_id *
Practice_id
abx_Improve * Year_
id * Practice_id
study_prob_def *
Year_id * Practice_id
result_1 * Year_id *
Practice_id
N Percent N Percent N Percent
Valid Missing Total
Cases
 
Lameness * Year_id * Practice_id Crosstabulation
116 21 137
97.5% 95.5% 97.2%
3 1 4
2.5% 4.5% 2.8%
119 22 141
100.0% 100.0% 100.0%
10 13 56 352 189 33 653
35.7% 26.5% 49.1% 81.3% 82.2% 62.3% 72.0%
18 36 58 81 41 20 254
64.3% 73.5% 50.9% 18.7% 17.8% 37.7% 28.0%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
Lamenes
Total
No
Yes
Lamenes
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Fever * Year_id * Practice_id Crosstabulation
117 22 139
98.3% 100.0% 98.6%
2 0 2
1.7% .0% 1.4%
119 22 141
100.0% 100.0% 100.0%
13 19 62 330 179 34 637
46.4% 38.8% 54.4% 76.2% 77.8% 64.2% 70.2%
6 11 24 64 39 11 155
21.4% 22.4% 21.1% 14.8% 17.0% 20.8% 17.1%
9 19 28 39 12 8 115
32.1% 38.8% 24.6% 9.0% 5.2% 15.1% 12.7%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
None
Any Eleva
Feve
Total
None
Any Eleva
>103
Feve
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.002001.002002.002003.002004.002005.00
Year_id
Total
 
Articular * Year_id * Practice_id Crosstabulation
119 22 141
100.0% 100.0% 100.0%
119 22 141
100.0% 100.0% 100.0%
27 48 112 429 229 51 896
96.4% 98.0% 98.2% 99.1% 99.6% 96.2% 98.8%
1 1 2 4 1 2 11
3.6% 2.0% 1.8% .9% .4% 3.8% 1.2%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Ye
Count
% within Ye
Count
% within Ye
Count
% within Ye
Count
% within Ye
NoArticul
Total
No
Yes
Articul
Total
Practice_id
Accomack
Animal Hos
Eastern Sho
Animal Hos
2000.002001.002002.002003.002004.002005.00
Year_id
Total
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Lymph * Year_id * Practice_id Crosstabulation
117 22 139
98.3% 100.0% 98.6%
2 0 2
1.7% .0% 1.4%
119 22 141
100.0% 100.0% 100.0%
26 40 106 414 221 49 856
92.9% 81.6% 93.0% 95.6% 96.1% 92.5% 94.4%
2 9 8 19 9 4 51
7.1% 18.4% 7.0% 4.4% 3.9% 7.5% 5.6%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Year_
Count
% within Year_
Count
% within Year_
Count
% within Year_
Count
% within Year_
Count
% within Year_
No
Yes
Lymph
Total
No
Yes
Lymph
Total
Practice_id
Accomack
Animal Hospita
Eastern Shore
Animal Hospita
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
Anorex * Year_id * Practice_id Crosstabulation
116 22 138
97.5% 100.0% 97.9%
3 0 3
2.5% .0% 2.1%
119 22 141
100.0% 100.0% 100.0%
19 37 88 412 216 46 818
67.9% 75.5% 77.2% 95.2% 93.9% 86.8% 90.2%
9 12 26 21 14 7 89
32.1% 24.5% 22.8% 4.8% 6.1% 13.2% 9.8%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
Anore
Total
No
Yes
Anore
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Malaise * Year_id * Practice_id Crosstabulation
114 21 135
95.8% 95.5% 95.7%
5 1 6
4.2% 4.5% 4.3%
119 22 141
100.0% 100.0% 100.0%
14 35 78 400 207 42 776
50.0% 71.4% 68.4% 92.4% 90.0% 79.2% 85.6%
14 14 36 33 23 11 131
50.0% 28.6% 31.6% 7.6% 10.0% 20.8% 14.4%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
Malaise
Total
No
Yes
Malaise
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
abx_Improve * Year_id * Practice_id Crosstabulation
109 21 130
91.6% 95.5% 92.2%
10 1 11
8.4% 4.5% 7.8%
119 22 141
100.0% 100.0% 100.0%
6 13 64 314 184 49 630
21.4% 26.5% 56.1% 72.5% 80.0% 92.5% 69.5%
22 36 50 119 46 4 277
78.6% 73.5% 43.9% 27.5% 20.0% 7.5% 30.5%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
abx_Impro
Total
No
Yes
abx_Impro
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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study_prob_def * Year_id * Practice_id Crosstabulation
119 22 141
00.0% 00.0% 00.0%
119 22 141
00.0% 00.0% 00.0%
24 42 102 428 228 50 874
85.7% 85.7% 89.5% 98.8% 99.1% 94.3% 96.4%
4 7 12 5 2 3 33
14.3% 14.3% 10.5% 1.2% .9% 5.7% 3.6%
28 49 114 433 230 53 907
00.0% 00.0% 00.0% 00.0% 00.0% 00.0% 00.0%
Count
% within Ye
Count
% within Ye
Count
% within Ye
Count
% within Ye
Count
% within Ye
Does Not mee
Probable
study_prob
Total
Does Not mee
Probable
Meets Study P
study_prob
Total
Practice_id
Accomack
Animal Hos
Eastern Sh
Animal Hos
2000.002001.002002.002003.002004.002005.00
Year_id
Total
 
result_1 * Year_id * Practice_id Crosstabulation
4 2 6
3.4% 9.1% 4.3%
115 20 135
96.6% 90.9% 95.7%
119 22 141
100.0% 100.0% 100.0%
12 20 10 6 9 5 62
42.9% 40.8% 8.8% 1.4% 3.9% 9.4% 6.8%
13 25 98 421 217 43 817
46.4% 51.0% 86.0% 97.2% 94.3% 81.1% 90.1%
3 4 6 6 4 5 28
10.7% 8.2% 5.3% 1.4% 1.7% 9.4% 3.1%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Year
Count
% within Year
Count
% within Year
Count
% within Year
Count
% within Year
Count
% within Year
Count
% within Year
Missing
Positive
result_1
Total
Missing
Positive
Negative
result_1
Total
Practice_id
Accomack
Animal Hospit
Eastern Shore
Animal Hospit
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Crosstabs 
 
 
Case Processing Summary
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
1048 100.0% 0 .0% 1048 100.0%
Lameness * Year_id
* Practice_id
Fever * Year_id *
Practice_id
abx_Improve * Year_
id * Practice_id
result_1 * Year_id *
Practice_id
study_prob_def *
Year_id * Practice_id
N Percent N Percent N Percent
Valid Missing Total
Cases
 
 
Lameness * Year_id * Practice_id Crosstabulation
116 21 137
97.5% 95.5% 97.2%
3 1 4
2.5% 4.5% 2.8%
119 22 141
100.0% 100.0% 100.0%
10 13 56 352 189 33 653
35.7% 26.5% 49.1% 81.3% 82.2% 62.3% 72.0%
18 36 58 81 41 20 254
64.3% 73.5% 50.9% 18.7% 17.8% 37.7% 28.0%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
Lamenes
Total
No
Yes
Lamenes
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
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Fever * Year_id * Practice_id Crosstabulation
117 22 139
98.3% 100.0% 98.6%
2 0 2
1.7% .0% 1.4%
119 22 141
100.0% 100.0% 100.0%
13 19 62 330 179 34 637
46.4% 38.8% 54.4% 76.2% 77.8% 64.2% 70.2%
6 11 24 64 39 11 155
21.4% 22.4% 21.1% 14.8% 17.0% 20.8% 17.1%
9 19 28 39 12 8 115
32.1% 38.8% 24.6% 9.0% 5.2% 15.1% 12.7%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
None
Any Elevat
Fever
Total
None
Any Elevat
>103
Fever
Total
Practice_id
Accomack
Animal Hospi
Eastern Shor
Animal Hospi
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
 
abx_Improve * Year_id * Practice_id Crosstabulation
109 21 130
91.6% 95.5% 92.2%
10 1 11
8.4% 4.5% 7.8%
119 22 141
100.0% 100.0% 100.0%
6 13 64 314 184 49 630
21.4% 26.5% 56.1% 72.5% 80.0% 92.5% 69.5%
22 36 50 119 46 4 277
78.6% 73.5% 43.9% 27.5% 20.0% 7.5% 30.5%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
No
Yes
abx_Impro
Total
No
Yes
abx_Impro
Total
Practice_id
Accomack
Animal Hosp
Eastern Sho
Animal Hosp
2000.002001.002002.002003.002004.002005.00
Year_id
Total
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result_1 * Year_id * Practice_id Crosstabulation
4 2 6
3.4% 9.1% 4.3%
115 20 135
96.6% 90.9% 95.7%
119 22 141
100.0% 100.0% 100.0%
12 20 10 6 9 5 62
42.9% 40.8% 8.8% 1.4% 3.9% 9.4% 6.8%
13 25 98 421 217 43 817
46.4% 51.0% 86.0% 97.2% 94.3% 81.1% 90.1%
3 4 6 6 4 5 28
10.7% 8.2% 5.3% 1.4% 1.7% 9.4% 3.1%
28 49 114 433 230 53 907
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Count
% within Yea
Missing
Positive
result_1
Total
Missing
Positive
Negativ
result_1
Total
Practice_id
Accomack
Animal Hosp
Eastern Shor
Animal Hosp
2000.00 2001.00 2002.00 2003.00 2004.00 2005.00
Year_id
Total
 
 
study_prob_def * Year_id * Practice_id Crosstabulation
119 22 141
00.0% 00.0% 00.0%
119 22 141
00.0% 00.0% 00.0%
24 42 102 428 228 50 874
85.7% 85.7% 89.5% 98.8% 99.1% 94.3% 96.4%
4 7 12 5 2 3 33
14.3% 14.3% 10.5% 1.2% .9% 5.7% 3.6%
28 49 114 433 230 53 907
00.0% 00.0% 00.0% 00.0% 00.0% 00.0% 00.0%
Count
% within Y
Count
% within Y
Count
% within Y
Count
% within Y
Count
% within Y
Does Not me
Probable
study_pro
Total
Does Not me
Probable
Meets Study 
study_pro
Total
Practice_i
Accomack
Animal Ho
Eastern S
Animal Ho
2000.002001.002002.002003.002004.002005.00
Year_id
Total
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Crosstabs 
 
Case Processing Summary
1048 100.0% 0 .0% 1048 100.0%
abx_Used *
study_prob_def
N Percent N Percent N Percent
Valid Missing Total
Cases
 
abx_Used * study_prob_def Crosstabulation
1 0 1
100.0% .0% 100.0%
1014 33 1047
96.8% 3.2% 100.0%
1015 33 1048
96.9% 3.1% 100.0%
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